Here's why the EMvision share price surged 8% on Wednesday

Investors appear happy about an agreement EMvision has struck with tech company Keysight Technologies.

| More on:
A guy wearing glasses tries to show off his muscles.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • EMvision shares are racing higher today following a company update
  • The company has entered into a strategic agreement with a long-term partner Keysight Technologies
  • In the last 12 months the EMvision share price has fallen more than 38%

The EMvision Medical Devices Ltd (ASX: EMV) share price has emerged from a trading halt on Wednesday morning, and shot 8% into the green.

Prior to their halt, EMVision shares closed at $1.94. Upon returning to trade, they have been sitting in the green amid the release of a company announcement. At the time of writing, EMvision shares are swapping hands at $2.05.

What did EMVision announce?

The company advised it has entered into an original equipment manufacturer (OEM) agreement with Keysight Technologies Inc (NYSE: KEYS).

According to the release, "Keysight is the world leader in radiofrequency (RF) test and measurement technology". Specifically, the company signed its agreement with Keysight's Australian subsidiary.

Under the agreement, EMvision will receive exclusive supply for 'fast sweep' features in the vector network analyser (VNA).

For reference, EMvision says the VNA is a custom solution developed in collaboration with Keysight.

"The VNA is a high performance, lower component count, miniaturised module responsible for accurate signal measurement," states the release.

"The custom VNA represents a strategic investment by Keysight into the electromagnetic imaging sector."

Regarding the announcement, EMvision CEO Dr Ron Weinberger says the collaboration "has been first class".

This Agreement recognises the roles that both parties have played in the development of the bespoke VNA over a period of 3 years. I would like to thank the Keysight team for their concerted work in developing a best-of-breed solution for EMvision and look forward to the commercial phase of our relationship.

Noteworthy is that Keysight is not a medical device manufacturer. However, it does possess "the strongest portfolio of Vector Network Analysers (VNA), which are core to the sensors that are being used inside EMvision's portable brain scanner," says the company.

The agreement builds on a relationship that spawned back in 2019. Then, the pair entered into a strategic collaboration to develop "custom healthcare-focused VNA solutions".

EMvision share price snapshot

In the last 12 months the EMvision share price has fallen more than 38%. Meanwhile, it is 23.5% in the red since trading resumed this year.

Following this announcement, shares have bounced from a low point and are tracking back towards monthly highs.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended EMvision Medical Devices Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A young woman carefully adds a rock to the top of a pile of balanced river rocks.
Technology Shares

Up 170% in a year, why this under-the-radar ASX tech stock still 'stacks up'

This stock has been catapulted higher. A fund manager is confident on more growth.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Technology Shares

This ASX All Ords stock is up 48% in under 2 months! Why there's 'more good news to come'

Australian fund manager Forager says this company has undergone "an amazing turnaround".

Read more »

Technology Shares

3 explosive ASX tech shares to buy this month

Analysts think these tech stocks could be great options for Aussie investors in January.

Read more »

A joyful woman in a wheelchair on a beach holds a bunch of colourful balloons and spreads her arms wide towards the sunset.
Technology Shares

Up 180% in 12 months, this ASX share is predicted to keep rising

This soaring stock still has a lot of potential.

Read more »

Technology Shares

4 reasons WiseTech shares can keep roaring higher in 2025

A leading expert forecasts more outperformance from WiseTech shares in 2025.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Technology Shares

Pro Medicus shares rocketed 161% in 2024: Is it still a buy?

Let's see whether analysts think this high-flying stock can keep rising.

Read more »

Happy man and woman looking at the share price on a tablet.
Technology Shares

3 ASX tech shares to buy in January

Analysts are tipping these shares as buys this month. Let's see what they are saying.

Read more »

Three people skydiving.
52-Week Lows

These ASX tech stocks just hit multi-year lows! Are they cheap?

A cheap share isn't always a bargain...

Read more »